Chris Freeman
Chief Commercial Officer · 3 filings · Latest: May 22, 2026
Guardant Health, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
GH | Chris Freeman | Chief Commercial Officer | May 22, 2026 | Sale | $118.67 | 24,406 | $2.9M | 60,034 | |
GH | Chris Freeman | Chief Commercial Officer | May 22, 2026 | Option Exercise | $32.86 | 24,406 | $802.0K | 84,440 | |
GH | Chris Freeman | Chief Commercial Officer | Apr 1, 2026 | Tax Withholding | $91.15 | 4,750 | $433.0K | 60,034 | |
GH | Chris Freeman | Chief Commercial Officer | Apr 1, 2026 | Option Exercise | $0.00 | 11,213 | — | 64,784 | |
GH | Chris Freeman | Chief Commercial Officer | Mar 15, 2026 | Tax Withholding | $85.49 | 7,127 | $609.3K | 53,571 | |
GH | Chris Freeman | Chief Commercial Officer | Mar 15, 2026 | Option Exercise | $0.00 | 16,828 | — | 60,698 |